Brief: Nicox Initiates Second Phase 3 Trial Of NCX 470 In Glaucoma

Ocumension Therapeutics

10/11/2020 06:42

Nov 10 (Reuters) - Nicox SA  NCOX.PA :
    * REG-NICOX INITIATES SECOND PHASE 3 TRIAL OF NCX 470 IN GLAUCOMA
    * DENALI TRIAL WILL BE EQUALLY FUNDED BY NICOX AND OCUMENSION
    * TOGETHER WITH MONT BLANC PHASE 3 TRIAL, DENALI WILL SUPPORT NEW DRUG APPLICATION (NDA)
SUBMISSIONS IN U.S. AND CHINA

Source text for Eikon:  ID:nGNELzsD0 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))